J L Liesveld
Overview
Explore the profile of J L Liesveld including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
654
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maziarz R, Brazauskas R, Chen M, McLeod A, Martino R, Wingard J, et al.
Bone Marrow Transplant
. 2016 Dec;
52(2):270-278.
PMID: 27991895
Patients with prior invasive fungal infection (IFI) increasingly proceed to allogeneic hematopoietic cell transplantation (HSCT). However, little is known about the impact of prior IFI on survival. Patients with pre-transplant...
2.
Callahan K, Minhajuddin M, Corbett C, Lagadinou E, Rossi R, Grose V, et al.
Leukemia
. 2014 Mar;
28(10):1960-8.
PMID: 24577530
Identification of agents that target human leukemia stem cells is an important consideration for the development of new therapies. The present study demonstrates that rocaglamide and silvestrol, closely related natural...
3.
Bachanova V, Marks D, Zhang M, Wang H, de Lima M, Aljurf M, et al.
Leukemia
. 2013 Aug;
28(3):658-65.
PMID: 23989431
The efficacy of reduced intensity conditioning (RIC) allogeneic hematopoietic cell transplantation (HCT) for Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL) is uncertain. We analyzed 197 adults with Ph+ ALL...
4.
Sung A, Grima D, Bernard L, Brown S, Carrum G, Holmberg L, et al.
Bone Marrow Transplant
. 2013 Jun;
48(11):1444-9.
PMID: 23749109
Chemotherapy plus G-CSF (C+G) and G-CSF alone are two of the most common methods used to mobilize CD34(+) cells for autologous hematopoietic SCT (AHSCT). In order to compare and determine...
5.
Liesveld J, Rothberg P
Bone Marrow Transplant
. 2008 Jul;
42(5):297-310.
PMID: 18660844
Stem cell transplants that follow both myeloablative and non-myeloablative conditioning regimens can result in states of mixed chimerism, which can be stable over time. With widespread availability of Y chromosome...
6.
Blumberg N, Heal J, Liesveld J, Phillips G, Rowe J
Leukemia
. 2007 Sep;
22(3):631-5.
PMID: 17805333
No abstract available.
7.
Walker A, Rothberg P, Liesveld J
Bone Marrow Transplant
. 2007 Apr;
39(11):725-6.
PMID: 17401398
No abstract available.
8.
Heal J, Liesveld J, Phillips G, Blumberg N
Bone Marrow Transplant
. 2005 Jul;
36(9):747-55.
PMID: 16044140
ABO blood group antigens, of great importance in transplantation and transfusion, are present on virtually all cells, as well as in soluble form in plasma and body fluids. Naturally occurring...
9.
Phillips G, Abboud C, Bernstein S, Friedberg J, Ifthikharuddin J, Lancet J, et al.
Semin Oncol
. 2005 Feb;
31(6 Suppl 18):59-61.
PMID: 15726525
We and others have previously shown that the use of amifostine (Ethyol; MedImmune Inc, Gaithersburg, MD) can ameliorate certain regimen-related toxicities of high-dose melphalan (HD-MEL) in the autologous hematopoietic stem...
10.
Horan J, Liesveld J, Fenton P, Blumberg N, Walters M
Bone Marrow Transplant
. 2004 Nov;
35(2):171-7.
PMID: 15531901
Patients with sickle cell disease (N = 3) and thalassemia (N = 1) with high-risk features received hematopoietic stem cell transplantations (HCT) to induce stable (full or partial) donor engraftment....